Electra Therapeutics Statistics
NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.11-0.83 (-9.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Electra Therapeutics by the numbers
Electra Therapeutics has a market capitalization of $509.8 million based on 62.87M shares outstanding. With trailing EPS of $-35.94, Electra Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.1% below its 50-day average and 14.1% below its 200-day average.
Average daily trading volume is 559.28K shares, or about $4.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ETRA valuation vs. peer median
| Metric | ETRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $509.85M | $487.20M | +5% |
| Avg. volume | 559.28K | 702.67K | -20% |
Peer median across 8 companies: VALN, DNA, SANA, RGNX, FENC, DBVT, ENTX, FDMT.
Valuation
- Market cap
- $509.85M
- EPS (TTM)
- $-35.94
- Shares outstanding
- 62.87M
Price and trading
- Previous close
- 8.94
- Open
- 8.85
- Day range
- 8.07 – 9.65
- 52-week range
- 6.87 – 15.50
- Beta
- —
- Volume
- 376.12K
- Average volume
- 559.28K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 509.85M
- Forward Pe
- -4.24
- Eps
- -35.94
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.50
- Week52 Low
- 6.87
- Avg Volume
- 559.28K
- Shares Outstanding
- 62.87M
- Ma50
- 9.44
- Ma200
- 9.44
- Pct From52w High
- -47.68%
- Pct From52w Low
- 18.05%